If you’ve spent time in functional medicine circles, fertility forums, or mental health communities online, you’ve almost certainly encountered MTHFR. It gets discussed more than almost any other gene in the wellness space, and the conversation ranges from precise and evidence-based to wildly overblown. People are told it causes everything from miscarriages to depression to cardiovascular disease. Others are told it’s been overhyped and doesn’t matter much at all. The truth sits somewhere more nuanced than either extreme.
MTHFR is a real gene with real biological significance. Variants in it genuinely affect how the body processes folate, how efficiently it clears a compound called homocysteine, and by extension, how well a range of downstream processes function — from DNA synthesis to neurotransmitter production to methylation of genes and proteins throughout the body. What’s less true is that having an MTHFR variant is a diagnosis of disease, or that the consequences are the same for everyone who carries one.
Understanding what this gene actually does, which variants matter and how much, and what practical steps make sense based on your specific result is genuinely useful information. It’s also the kind of information that benefits from precision — because the recommendations differ meaningfully depending on which variant you have and whether you carry one copy or two.
Contents
What the MTHFR Gene Does
MTHFR stands for methylenetetrahydrofolate reductase — the enzyme the gene encodes. That enzyme performs one specific, critical job: it converts a form of folate called 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, which is the active form the body can actually use.
Why does that conversion matter? Because 5-methyltetrahydrofolate — often written as 5-MTHF or methylfolate — is the fuel for the methylation cycle. Methylation is a fundamental biochemical process in which a methyl group (one carbon atom bonded to three hydrogen atoms) is transferred from one molecule to another. This happens billions of times per second throughout the body and is involved in DNA synthesis and repair, gene expression regulation, production of neurotransmitters like serotonin, dopamine, and norepinephrine, detoxification of hormones and environmental compounds, and the conversion of homocysteine to methionine.
That last point is particularly important. Homocysteine is an amino acid produced as a byproduct of protein metabolism. At elevated levels, it becomes toxic to blood vessels and is associated with increased cardiovascular risk, cognitive decline, and pregnancy complications. The MTHFR enzyme — fueled by active methylfolate — is a key driver of the process that clears homocysteine from circulation. When MTHFR activity is reduced, homocysteine can accumulate.
The Two Variants That Matter Most
There are hundreds of known variants in the MTHFR gene, but two have been studied extensively enough to have clear clinical relevance: C677T (rs1801133) and A1298C (rs1801131).
C677T is the more significant of the two. It involves a single nucleotide change at position 677 of the gene — a cytosine (C) replaced by a thymine (T) — that results in a structural change to the MTHFR enzyme, making it less stable and less efficient, particularly at normal body temperature. People who inherit one copy of this variant (heterozygous, written CT) experience roughly a 35 percent reduction in MTHFR enzyme activity compared to people with two typical copies (CC). People who inherit two copies (homozygous, written TT) experience a reduction of approximately 70 percent. The TT genotype is found in around 10 to 15 percent of people of European ancestry, though rates vary by population.
A1298C (rs1801131) involves a different position in the gene and has a more modest effect on enzyme activity when present alone. It’s generally considered less clinically impactful in isolation than C677T, but carrying variants at both positions — one A1298C and one C677T, known as compound heterozygosity — produces a combined reduction in enzyme activity that can be significant.
The effect of either variant is dose-dependent: one copy produces partial reduction, two copies (or a combination) produce greater reduction. This is why knowing your specific genotype matters more than simply knowing whether you “have MTHFR.”
How MTHFR Variants Affect Folate and Homocysteine
The most direct consequence of reduced MTHFR activity is impaired conversion of dietary folate into its active, usable form. This creates a functional folate deficiency that can exist even when blood folate levels appear normal — because standard folate tests measure total folate in circulation, not the proportion that has been successfully converted to the active methylfolate the body needs.
This distinction matters for supplementation. Standard folic acid — the synthetic form found in most multivitamins and added to fortified foods — requires the MTHFR enzyme to convert it into active methylfolate before the body can use it. For people with significant MTHFR variants, that conversion is impaired. Taking high doses of folic acid doesn’t compensate for reduced enzyme activity; it just means more unconverted folic acid accumulates, which some research suggests may have its own adverse effects.
The practical implication is that people with MTHFR variants often respond better to methylfolate (5-MTHF) supplementation — the pre-converted, active form — rather than standard folic acid. Similarly, vitamin B12 is most useful in the methylcobalamin form rather than cyanocobalamin, because methylcobalamin participates directly in the methylation cycle without requiring additional conversion steps. Riboflavin (vitamin B2) is also relevant, because it’s a cofactor required for MTHFR enzyme function — and some research suggests riboflavin supplementation can partially compensate for reduced MTHFR activity, particularly in people with the TT genotype.
What MTHFR Variants Are and Aren’t Linked To
The research on MTHFR health associations is extensive but uneven in quality and consistency. Some connections are reasonably well-supported; others remain debated.
The strongest established association is with neural tube defects in pregnancy. Women with MTHFR C677T homozygosity (TT) have elevated risk of pregnancies affected by neural tube defects such as spina bifida. This is the basis for the recommendation that women of reproductive age take adequate folate — and for women with MTHFR variants specifically, adequate methylfolate — before and during early pregnancy. Adequate folate status is protective regardless of MTHFR status, but ensuring the form of folate taken is actually usable matters more when MTHFR activity is reduced.
The association with elevated homocysteine is also well-established for people with the TT genotype, and elevated homocysteine is independently associated with cardiovascular risk. Whether MTHFR variants themselves directly increase cardiovascular risk beyond their effect on homocysteine has been debated in large meta-analyses, with mixed results — the relationship appears to be real but modest and influenced by dietary folate status.
Associations with mental health conditions including depression, anxiety, and schizophrenia have been studied extensively. The biological plausibility is reasonable — methylation is required for neurotransmitter synthesis, and impaired methylfolate production could affect serotonin and dopamine pathways. Some studies show associations; others don’t. The relationship is likely real in at least a subset of people, but MTHFR is one of many genetic contributors to mental health, not a primary cause.
Migraines with aura show a reasonably consistent association with C677T, possibly related to effects on nitric oxide metabolism and vascular function. Recurrent pregnancy loss has also been studied as a potential association, though evidence here is more mixed and guidelines vary on clinical management.
What Not to Do With an MTHFR Result
One thing that happens frequently when people discover they have an MTHFR variant is that they start supplementing aggressively with high-dose methylfolate and methyl-B12 without guidance. This can cause problems. Some people — particularly those who are homozygous for C677T — are sensitive to high doses of methylated supplements and experience side effects including anxiety, irritability, insomnia, and a sense of overstimulation. Starting at low doses and titrating slowly is consistently recommended for this reason.
It’s also worth being cautious about very high doses of niacin (vitamin B3) if you have MTHFR variants, since niacin can consume methyl groups and reduce methylation capacity — potentially counteracting efforts to support the methylation cycle. And avoiding high-dose folic acid makes sense for people with significant variants, since unconverted folic acid may compete with methylfolate at the cellular level.
Working with a healthcare provider who understands methylation biochemistry — an integrative physician, functional medicine practitioner, or knowledgeable naturopath — is more useful than self-managing based on a single gene result. MTHFR sits within a broader methylation cycle involving multiple other genes, including MTR, MTRR, COMT, BHMT, and CBS, and understanding the full picture produces better outcomes than treating MTHFR in isolation.
Know Your MTHFR Status
The SelfDecode MTHFR Gene Deep Dive report analyzes the two clinically significant MTHFR variants — C677T (rs1801133) and A1298C (rs1801131) — and delivers up to 11 personalized, DNA-based recommendations covering folate form, homocysteine management, riboflavin status, diet, and life decisions. It explains what your specific genotype means for cardiovascular health, fertility, brain function, and methylation — and which interventions apply to you specifically. Compatible with existing 23andMe and AncestryDNA raw data.